Epizyme (EPZM) Financials

$1.47

$0.00 (0.00%)

As on 12-Aug-2022 09:30EDT

Market cap

$248 Mln

Revenue (TTM)

$53 Mln

P/E Ratio

--

P/B Ratio

14.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	53.01	37.43	15.76	23.80	21.70	10.00
Cost of Revenue	12.95	10.50	5.07	132.64	105.83	109.66
Gross Profit	40.06	26.93	10.70	23.80	21.70	10.00
Operating Expenses	236.21	264.92	236.11	200.94	149.81	146.84
Operating Profit (EBIT)	-196.16	-237.99	-225.42	-177.14	-128.11	-136.84
Other Income	10.91	9.34	-1.38	-0.21	-0.03	2.20
Profit before Tax	-207.68	-251.10	-231.58	-170.24	-123.57	-134.65
Provision for Tax	0.05	0.02	0.11	0.06	0.06	-0.34
Profit after Tax (Net Income)	-207.73	-251.12	-231.69	-170.30	-123.63	-134.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-207.73	-251.12	-231.69	-173.24	-123.63	-134.31

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-20.28	-20.69	184.90	331.14	233.01	235.37
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	249.49	264.49	245.28	59.07	4.66	29.32
Current Liabilities	34.95	45.20	43.40	34.39	37.83	24.66
Total Liabilities	299.11	289.00	473.57	424.59	275.50	289.36

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	77.32	82.96	68.48	25.41	2.97	3.56
Current Assets	186.84	206.04	405.09	399.18	272.54	285.80
Total Assets	299.11	289.00	473.57	424.59	275.50	289.36
Total Debt*	237.71	239.11	235.74	45.47	0.07	0.11
Net Current Assets	151.89	160.85	361.69	364.79	234.70	261.14

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-226.85	-206.34	-147.17	-121.60	-120.43
Cash Flow from Investing Activities	--	125.48	-14.59	-85.32	-102.61	113.33
Cash from Financing Activities	--	31.49	249.66	286.35	84.21	155.87
Net Cash Inflow / Outflow	--	-69.88	28.73	53.86	-139.99	148.77

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-1.73	-2.44	-2.29	-1.89	-1.72	-2.20
Cash EPS ($)	--	-2.39	-2.25	-1.88	-1.70	-2.17
Adjusted Book Value ($)	--	--	1.83	3.68	3.24	3.86
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.20	-2.04	-1.64	-1.69	-1.97
Free Cash Flow per Share ($)	--	-2.21	-2.55	-1.64	-1.69	-1.99

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-78.59	-58.12	-55.86	-52.77	-61.34
ROE (%)	--	-305.86	-89.80	-60.37	-52.79	-61.46
ROA (%)	-59.99	-65.86	-51.59	-48.65	-43.77	-49.58
EBIT Margin (%)	-346.35	-606.35	-1,430.75	-714.47	-569.46	-1,346.45
Net Margin (%)	-325.03	-536.99	-1,611.34	-721.74	-570.38	-1,101.16
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	62.69	1.37	-0.34	0.10	1.17	0.25
EBIT Growth (%)	23.94	-0.63	-32.62	-37.61	8.22	-22.17
Net Profit Growth (%)	19.15	-8.39	-36.05	-37.75	7.95	-21.86
EPS Growth (%)	31.48	-0.06	-0.21	-0.10	0.22	-0.14
Book Value Growth (%)	-118.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-1.03	-4.73	-13.00	-3.59	-5.70
Price / Book Value	14.84	-12.45	5.93	6.69	1.90	3.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.91	-1.44	-4.33	-11.10	-1.66	-3.68
Close Price ($)	1.47	2.50	10.86	24.60	6.16	12.55
High Price ($)	8.52	12.69	27.82	25.00	21.40	20.45
Low Price ($)	0.41	2.50	9.90	5.81	5.14	9.30
Market Cap ($ Cr)	247.50	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-10.69	-11.56	1.28	0.14	0.00	0.00
Short term debt to equity ratio	-0.26	-0.20	0.03	0.01	0.00	0.00
Current Ratio	5.35	4.56	9.33	11.61	7.20	11.59
Quick Ratio	5.19	4.49	9.09	--	--	11.59
Interest Coverage	-7.62	-9.39	-37.18	-885.65	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	21.15	17.75	22.04	14.75	95.60	6.31
Asset Turnover	0.15	0.10	0.04	0.07	0.08	0.04
Receivable days	--	49.37	80.92	186.12	179.91	17.33
Inventory Days	--	237.93	754.07	--	--	--
Payable days	--	355.37	682.82	18.67	20.33	19.98
Cash Conversion Cycle	--	-68.07	152.17	--	159.58	-2.64

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.